Charles R. Lambert, M.D., Ph.D., M.B.A.
Medical Director
Pepin Heart Hospital and Kiran Patel Research Institute
M.D.,University of Florida
Ph.D., Physiology, University of Florida
M.B.A., University of Massachusetts
Biographical Sketch
Dr. Lambert received an M.D. and Ph.D. in physiology from the University of Florida and Master of Business Administration from the Isenberg School of Management at the University of Massachusetts. He did residency in internal medicine, fellowship in cardiology and interventional cardiology and a postdoctoral research fellowship all at the University of Florida. Subsequently, Dr Lambert remained on the faculty as Director of the cardiac catheterization laboratories until being appointed as Abraham Mitchell Eminent Scholar in Cardiology at the University of South Alabama College of Medicine and Hospitals. He returned to the University of Florida faculty to direct a cardiovascular affiliation with Health First, a three hospital integrated delivery system, along the Space Coast. More recently, Dr Lambert has served as Director of Interventional Cardiology at the University of Florida and Shands Hospital. The affiliation between USF and University Community Health brought Dr. Lambert to the College of Medicine as Medical Director of the Pepin Heart Hospital and Kiran Patel Research Institute.
Areas of Expertise
- Interventional cardiology
- Peripheral vascular intervention
- Digital Imaging and signal processing
- Hemodynamics and coronary physiology
- Medical informatics and outcomes analysis
- Cardiovascular management and decision analysis
Current Research
- Hemodynamic Effects of EECP in Patients With LV Dysfunction
- Open Label Dose Escalation Study to Determine the Safety and Effect of CVT-3146 on Coronary Blood Flow in Subjects Undergoing Clinically Indicated Cardiac Catheterization
- Gathering Quantitative and Qualitative Data in Patients Undergoing Percutaneous Coronary Intervention With Quality of Life Assessment
- Cardioshield Protection During Transluminal Vein Graft Intervention
- Angiogenetic Gene Therapy protocol 304386: A Study to Evaluate Efficacy and Safety of Ad50FGF-4 in Patients With Stable Angina
- Bypass Angioplasty Revascularization Investigation 2 Diabetes
- Reduction of Vascular Inflammation and Coronary Atherosclerosis Reduces Cardiovascular Events in Patients with Coronary Artery Disease
- Acute Myocardial Infarction with Hyperoxemic Therapy
- Assessment of the Medtronic AVE Interceptor Saphenous Vein Graft Filter System
- A Randomized Double Blind Placebo Controlled Parallel Group Study of the Efficacy and Safety of the ACAT Inhibitor CS-505 for Reducing the Progression of Atherosclerosis in Subjects with Coronary Artery Disease using Intravascular Ultrasound
Selected Publications
Some thoughts on the vasculopathy of women with ischemic heart disease. C. J. Pepine, R. A. Kerensky, C. R. Lambert, K. A. Smith, G. O. von Mering, G. Sopko, C. N. Bairey Merz. Journal of the American College of Cardiology 47 (3) s30-35, 2006.
Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. J. J. Popma, M.B. Leon, J.W. Moses, D. R. Holmes, N. Cox, M. Fitzpatrick, J. Douglas, C. R. Lambert, M. Mooney, S. Yakubov, R. Kuntz. Circulation 110:3773-3780, 2004.
Design, implementation and performance of an academic-community health care system cardiovascular affiliation. C. R. Lambert, S.A. Bunker, L.A. Garrison, M.D. Means, C.J. Pepine, C.R. Conti, M.A. Dewar, T. Goldfarb. American Heart Hospital Journal, 4;2:86-94, 2006.